← Evidence map

ArticleFrontiers in medicine2022

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.

Youling Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes. | OpenQuestion